Belgium· BE-AMP-SAM509493-00
Cystadrops 3.8 mg/ml
A mercaptamine product containing mercaptamine hydrochloride, registered in Belgium by Recordati Rare Diseases. The same ATC class is registered in 13 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Mercaptamine is registered in 13 of 19 countries.
Countries holding a registration under ATC S01XA21 (mercaptamine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Mercaptamine · ATC S01XA21
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Mercaptamine Hydrochloride
- Manufacturer
- Recordati Rare Diseases
- Country
- Belgium (BE)
- ATC code
- S01XA21
- ATC class
- Mercaptamine
- Defined daily dose
- 0.4 ml, AT
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb7727399
- be_apb4182754
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mercaptamine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCYSTADROPSRecordati Rare Diseases, Puteaux
- FinlandCystadropsRecordati Rare Diseases
- FranceCYSTADROPS 3,8 mg/mL, collyre en solutionRECORDATI RARE DISEASES
- IrelandCystadrops 3.8 mg/mL eye drops solutionRecordati Rare Diseases
- IcelandCYSTADROPSRecordati Rare Diseases*
- NetherlandsCystadrops 3,8 mg/ml oogdruppels, oplossingOrphan Europe SARL
- NorwayCystadropsRecordati Rare Diseases
- PolandCystadropsRecordati Rare Diseases
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cystadrops, Cystagon
- Liechtenstein · Cystadrops, Cystagon
- Norway · Cystadrops, Cystagon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/38df562a-e1ab-4523-b53b-381d64ee1397 GET /v1/drugs/38df562a-e1ab-4523-b53b-381d64ee1397?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye drops, solution",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Cystadrops 3.8 mg/ml",
"name_fr": "Cystadrops 3.8 mg/ml",
"name_nl": "Cystadrops 3.8 mg/ml",
"amp_code": "SAM509493-00",
"strengths": [
"3.8000",
"3.8000",
"0.1000",
"0.1000"
],
"pack_count": 2,
"substances": [
"Mercaptamine Hydrochloride",
"Mercaptamine",
"Benzalkonium Chloride",
"Disodium Edetate",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Mercaptamine",
"authorisation_numbers": [
"EU/1/15/1049/001",
"EU/1/15/1049/002"
]
}See everything about mercaptamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.